Clinical Trial Update: T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study of T cell receptor-transduced T cells targeting NY-ESO-1 in patients with NY-ESO-1-expressing malignancies to assess safety and preliminary effica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Breast Cancer
• Esophageal Cancer
• Lung Cancer
• Melanoma
• Multiple Myeloma
• Neuroblastoma
• Ovarian Cancer

Drugs mentioned

• TCR-T NY-ESO-1 targeting T cells (T cell receptor-transduced T cells targeting NY-ESO-1)

Snippet

Sponsor: Shenzhen Second People's Hospital | Conditions: Bladder Carcinoma, Breast Cancer | Phase 1 | Status: UNKNOWN